UNSPSC 85542301: Revision of nonautologous tissue substitute in lymphatic, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in lymphatic, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07WN4KZ

UNSPSC 85542301 Revision of nonautologous tissue substitute in lymphatic, percutaneous endoscopic approach (Commodity) shows no recent state and local procurement activity aligned with its nominal medical device and surgical scope. The six opportunities posted between July and September 2026 span independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, occupational health surveillance, youth detention emergency services, pharmacy benefit management, and temporary health professional staffing — none of which involve tissue substitute revision or endoscopic lymphatic procedures. The code assignment appears to be a misclassification in the source data rather than a reflection of actual state and local purchasing demand under this Commodity tier.

The opportunities do reflect broad state and local engagement with healthcare administration, occupational medicine, and benefits management services across Arizona, California, Florida, and Washington, but they do not correspond to the implantable medical device or surgical intervention scope that UNSPSC 85542301 describes. Business development professionals should verify whether this code is actively used in state and local procurement or whether healthcare-related opportunities are being routed through family-level or class-level codes in the medical devices or clinical services hierarchies instead.